PetMed Express D/B/A 1-800-PetMeds Announces Its First Quarter Financial Results and Its $0.17 Per Share Quarterly Dividend

        Print
| Source: PetMed Express, Inc.

POMPANO BEACH, Fla., July 21, 2014 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (Nasdaq:PETS) today announced its financial results for the quarter ended June 30, 2014. Net income was $5.0 million, or $0.25 diluted per share, for the quarter ended June 30, 2014, compared to net income of $4.8 million, or $0.24 diluted per share, for the quarter ended June 30, 2013, a 4.6% increase to net income. Net sales for the quarter ended June 30, 2014 were $72.5 million, compared to $74.2 million for the quarter ended June 30, 2013, a decrease of 2.2%. The Company's online sales for the quarter ended June 30, 2014 were approximately 80% of all sales, compared to 79% for the same quarter the prior year.

Menderes Akdag, CEO and President, commented: "We were able to increase our gross margins for the second consecutive quarter and decrease our operational expenses to improve our bottom line results for the quarter ended June 30, 2014. For the quarter ended June 30, 2014 our gross profit increased by 40 basis points, which can be attributed to a cost reduction in certain brands. For the quarter ended June 30, 2014 our operational expenses decreased by 30 basis points, mainly due to a reduction in advertising spending. Despite our sales decrease for the quarter we were able to increase our average order size to $78 for the quarter ended June 30, 2014, compared to $77 for the same quarter in the prior year. For the remainder of Fiscal 2015 we are focusing on improving our marketing efforts to increase sales."

The Board of Directors declared a quarterly dividend of $0.17 per share on the Company's common stock. The dividend will be payable on August 15, 2014, to shareholders of record at the close of business on August 4, 2014. The Company intends to continue to pay regular quarterly dividends; however the declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company's financial performance.

This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the quarter's financial results. To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (203) 827-7025. Callers will be required to supply PETMEDS as the passcode. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on July 21, 2014 until August 4, 2014 at 11:59 P.M. To access the replay, call (866) 509-3896 (toll free) or (203) 369-1915, and enter passcode 5500.

Founded in 1996, PetMed Express is America's Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.

This press release may contain "forward-looking" statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company's ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such "forward-looking" statements are set forth in Management's Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2014. The Company's future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.

For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.

 
PETMED EXPRESS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
     
  June 30, March 31,
  2014 2014
ASSETS    
     
Current assets:    
Cash and cash equivalents  $ 29,141  $ 18,305
Short term investments - available for sale  15,567  15,539
Accounts receivable, less allowance for doubtful accounts of $6 and $7, respectively  1,598  1,761
Inventories - finished goods  32,887  35,727
Prepaid expenses and other current assets  1,516  1,761
Deferred tax assets  1,087  1,062
Prepaid income taxes  --   54
Total current assets  81,796  74,209
     
Noncurrent assets:    
Prepaid expenses  2,214  1,996
Property and equipment, net  1,153  1,310
Intangible assets  860  860
     
Total assets  $ 86,023  $ 78,375
     
LIABILITIES AND SHAREHOLDERS' EQUITY    
     
Current liabilities:    
Accounts payable  $ 8,589  $ 5,768
Accrued expenses and other current liabilities  2,406  2,325
Income taxes payable  2,889  -- 
Total current liabilities  13,884  8,093
     
Deferred tax liabilities  --   65
     
Total liabilities:  13,884  8,158
     
Commitments and contingencies    
     
Shareholders' equity:    
Preferred stock, $.001 par value, 5,000 shares authorized;
3 convertible shares issued and outstanding with a liquidation preference of $4 per share
 9  9
Common stock, $.001 par value, 40,000 shares authorized;
20,189 and 21,190 shares issued and outstanding, respectively
 20  20
Additional paid-in capital  1,950  1,578
Retained earnings  70,189  68,647
Accumulated other comprehensive loss  (29)  (37)
     
Total shareholders' equity  72,139  70,217
     
Total liabilities and shareholders' equity  $ 86,023  $ 78,375
 
 
 PETMED EXPRESS, INC. AND SUBSIDIARIES 
 CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME 
 (In thousands, except for per share amounts) (Unaudited) 
     
   Three Months Ended 
   June 30, 
  2014 2013
     
 Sales   $ 72,541  $ 74,194
 Cost of sales   48,769  50,181
     
 Gross profit   23,772  24,013
     
 Operating expenses:     
 General and administrative   5,875  5,873
 Advertising   9,896  10,395
 Depreciation   163  248
 Total operating expenses   15,934  16,516
     
 Income from operations   7,838  7,497
     
 Other income (expense):     
 Interest income, net   44  47
 Other, net   9  (2)
 Total other income   53  45
     
 Income before provision for income taxes   7,891  7,542
     
 Provision for income taxes   2,918  2,787
     
 Net income   $ 4,973  $ 4,755
     
 Net change in unrealized gain (loss) on short term investments   8  (46)
     
 Comprehensive income   $ 4,981  $ 4,709
     
 Net income per common share:     
 Basic   $ 0.25  $ 0.24
 Diluted   $ 0.25  $ 0.24
     
 Weighted average number of common shares outstanding:     
 Basic   19,961  19,848
 Diluted   20,092  20,004
     
 Cash dividends declared per common share   $ 0.17  $ 0.15
 
 
PETMED EXPRESS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands) (Unaudited) 
 
   Three Months Ended 
   June 30, 
  2014 2013
Cash flows from operating activities:     
Net income   $ 4,973  $ 4,755
Adjustments to reconcile net income to net cash provided by operating activities:     
Depreciation   163  248
Share based compensation   373  362
Deferred income taxes   (90)  35
Bad debt expense   17  24
(Increase) decrease in operating assets and increase (decrease) in liabilities:     
Accounts receivable   146  (1,112)
Inventories - finished goods   2,840  10,025
Prepaid income taxes   54  -- 
Prepaid expenses and other current assets   27  (609)
Accounts payable   2,821  3,818
Income taxes payable   2,889  2,474
Accrued expenses and other current liabilities   44  (175)
Net cash provided by operating activities   14,257  19,845
     
Cash flows from investing activities:     
Net change in investments   (20)  (21)
Purchases of property and equipment   (6)  (4)
Net cash used in investing activities   (26)  (25)
     
Cash flows from financing activities:     
Dividends paid   (3,395)  (2,977)
Net cash used in financing activities   (3,395)  (2,977)
     
Net increase in cash and cash equivalents   10,836  16,843
Cash and cash equivalents, at beginning of period   18,305  18,155
     
Cash and cash equivalents, at end of period   $ 29,141  $ 34,998
     
Supplemental disclosure of cash flow information:     
     
Cash paid for income taxes   $ 66  $ 279
     
Dividends payable in accrued expenses   $ 300  $ 315